Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-12

Clinical Trial Update: Effect of Saccharomyces Cerevisiae in LDL Cholesterol [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of Saccharomyces cerevisiae on LDL cholesterol in individuals with dyslipidemias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saccharomyces cerevisiae (Saccharomyces cerevisiae)

Snippet

Sponsor: Lesaffre International | Conditions: Dyslipidemias | NA | Status: COMPLETED